💉RFK Jr. Replaces Entire CDC Vaccine Panel: A Step Toward Transparency and Public Trust
- ketogenicfasting
- Jul 5
- 4 min read
Updated: Aug 1
In an unprecedented and long-overdue move, U.S. Health Secretary Robert F. Kennedy Jr. has replaced the entire Advisory Committee on Immunization Practices (ACIP)—the group responsible for advising the CDC (Center for Disease Control) on vaccine schedules and recommendations.
This sweeping change marks the beginning of a new era—one rooted in scientific independence, public accountability, and the principle of informed consent.
Importantly, this new ACIP panel is made up entirely of volunteers—respected scientists, physicians, and public health experts with no financial ties to vaccine manufacturers and no personal stake in pharmaceutical industry outcomes. That alone is a radical shift in how health policy is shaped in this country.
This is a step in the right direction: a return to ethical science, unbiased public service, and truly independent oversight of powerful industries.
Who Are the New ACIP Members?
Among the new members are voices long silenced or sidelined for raising valid safety concerns and insisting on robust debate. Now, they are at the table:
Dr. Robert Malone
A physician and virologist best known for his early work in developing mRNA vaccine technology, Dr. Malone has become a prominent critic of the pharmaceutical industry's influence over regulatory agencies. He brings decades of experience in clinical trials, vaccine development, and bioethics.
Prof. Retsef Levi
A professor at the MIT Sloan School of Management, Levi specializes in healthcare analytics, risk management, and public safety. He was one of the first academics to raise red flags about vaccine injury signal detection failures in real-world data during the COVID-19 pandemic.
Other appointees include:
Dr. Kat Lindley – Board-certified family physician and advocate for informed consent, known for her international work in patient-centered care.
Dr. Pierre Kory – Pulmonary and critical care specialist, co-founder of the FLCCC Alliance, and outspoken advocate for clinical autonomy.
Dr. Meryl Nass – Internist and longtime investigator of vaccine injury, with expertise in biodefense and medical ethics.
Dr. David Bell – Former WHO (World Health Organization) scientist and global health expert focused on infectious disease strategy and medical sovereignty.
Together, these individuals bring a refreshing diversity of backgrounds and a shared commitment to data integrity, medical ethics, and transparent public dialogue.
Full Interview with Dr. Robert Malone & Prof. Retsef Levi Now Released
The conversation, nearly two hours long, offers a deep look into their motivations, the restructuring of ACIP, and what this means for the future of vaccine policy in America.
“They basically impact billions of dollars of revenue for the pharmaceutical industry. So there's big money at stake here. There's big policy at stake,”— Dr. Robert Malone
“One of the problems that we had in the context of vaccines, and more broadly maybe pharmaceutical products, is that debate was considered confusing to patients and something that we should avoid,”— Prof. Retsef Levi
This interview unpacks key issues from the recent ACIP meeting, including discussion about the continued use of thimerosal (a mercury-based preservative still found in some flu vaccines), emerging concerns about RSV shots for infants, and the committee’s philosophy of public transparency moving forward.
Interview Chapter Highlights
0:00:00 - Introduction to ACIP and New Committee Members
0:09:09 - Understanding ACIP's Role and Influence
0:09:59 - Retsef Levi's Background and Approach to Public Health
0:13:11 - Robert Malone's Background
0:18:16 - The Importance of Open Debate in Medical Decision-Making
0:22:01 - Patient Empowerment and Personalized Healthcare
0:28:06 - Challenges in Public Health Data Analysis
0:31:03 - Influenza Vaccines and Thimerosal Removal
0:40:57 - Mercury Exposure and Vaccine Safety Concerns
0:47:10 - Immunotoxicity and Long-Term Vaccine Effects
0:55:07 - Efficacy vs. Harm: Data Collection Challenges
1:11:46 - RSV Shot Debate: Nuanced Perspectives
1:34:02 - Risk-Benefit Analysis for Infant Vaccination
1:37:46 - Closing Thoughts on ACIP's Future and Mission
The RSV shot helps protect babies and older adults from RSV, a common virus that can cause serious lung infections like bronchiolitis and pneumonia—especially in infants.
For babies, it’s typically not a traditional vaccine but a protective antibody injection that offers temporary immunity during RSV season.
Doctors often recommend it for newborns and high-risk infants. However, some parents have raised concerns about long-term safety, prompting the newly restructured ACIP committee to take a more critical look at the data and recommendations.
A Break from Business as Usual
For decades, many ACIP members held industry ties, consulted for pharmaceutical companies, or benefited financially from the products they helped approve. This new panel, by contrast, has no such conflicts of interest. Their service is voluntary, their motivations are public, and their mission is clear: to put science and safety first.
“What you're seeing here is a firm commitment on the part of these two volunteers, and I think the committee as a whole, in trying to be open and transparent to the general public.”— Dr. Robert Malone
With its renewed membership, ACIP may finally live up to what the public always assumed it was: a body that serves the people, not the pharmaceutical industry. And for the first time in a long time, many Americans are watching with cautious hope.
Commentaires